In the pathogenesis of AD, the MAPK pathway contributes to disease progression by inducing neuronal apoptosis, the transcription and activation of β- and γ-secretases, and the phosphorylation of Amyloid-beta precursor protein (APP) and tau. Here, APP is linked to Alzheimer disease.